tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BCRX Stock Latest News

BioCryst’s Orladeyo Pediatric Approval and Strategic Expansion Drive Buy Rating
RatingsBioCryst’s Orladeyo Pediatric Approval and Strategic Expansion Drive Buy Rating
13d ago
BCRX
BioCryst price target raised to $32 from $30 at H.C. Wainwright
PremiumThe Fly
BioCryst price target raised to $32 from $30 at H.C. Wainwright
13d ago
BCRX
BioCryst’s Avoralstat Study: A New Hope for Diabetic Macular Edema?
PremiumCompany Announcements
BioCryst’s Avoralstat Study: A New Hope for Diabetic Macular Edema?
14d ago
BCRX
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks
15d ago
ARTV
BCRX
BioCryst’s Growth Potential Bolstered by FDA Approval and Strategic Moves: A Buy Recommendation
PremiumRatings
BioCryst’s Growth Potential Bolstered by FDA Approval and Strategic Moves: A Buy Recommendation
16d ago
BCRX
BioCryst Gains FDA Approval for Pediatric HAE Drug
PremiumCompany AnnouncementsBioCryst Gains FDA Approval for Pediatric HAE Drug
16d ago
8K
BCRX
BioCryst announces FDA approved NDA for of ORLADEYO
Premium
The Fly
BioCryst announces FDA approved NDA for of ORLADEYO
16d ago
BCRX
BioCryst Announces Board Chair Transition Plan
Premium
Company Announcements
BioCryst Announces Board Chair Transition Plan
17d ago
8K
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
24d ago
BCRX
BioCryst Announces Early Termination for Astria Merger
PremiumCompany Announcements
BioCryst Announces Early Termination for Astria Merger
25d ago
8K
BCRX
BioCryst receives early termination of HSR waiting period for Astria acquisition
PremiumThe Fly
BioCryst receives early termination of HSR waiting period for Astria acquisition
25d ago
ATXS
BCRX
BioCryst announces new data at ACAAI on ORLADEYO
PremiumThe Fly
BioCryst announces new data at ACAAI on ORLADEYO
2M ago
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe FlyBioCryst reports inducement grants under Nasdaq listing rule
2M ago
BCRX
BioCryst price target lowered to $25 from $27 at Citizens JMP
Premium
The Fly
BioCryst price target lowered to $25 from $27 at Citizens JMP
2M ago
BCRX
BioCryst Pharmaceuticals Shines in Q3 Earnings Call
Premium
Company Announcements
BioCryst Pharmaceuticals Shines in Q3 Earnings Call
2M ago
BCRX
BioCryst’s Strong Growth and Strategic Moves Reinforce Buy Rating
PremiumRatings
BioCryst’s Strong Growth and Strategic Moves Reinforce Buy Rating
2M ago
BCRX
BioCryst price target lowered to $9 from $11 at Barclays
PremiumThe Fly
BioCryst price target lowered to $9 from $11 at Barclays
2M ago
BCRX
BioCryst Pharmaceuticals Reports Strong Q3 2025 Results
PremiumCompany Announcements
BioCryst Pharmaceuticals Reports Strong Q3 2025 Results
2M ago
BCRX
BioCryst’s Orladeyo: Strong Growth and Strategic Moves Reinforce Buy Rating
PremiumRatings
BioCryst’s Orladeyo: Strong Growth and Strategic Moves Reinforce Buy Rating
2M ago
BCRX
BioCryst Reports Q3 2025 Financial Growth and Strategy
PremiumCompany AnnouncementsBioCryst Reports Q3 2025 Financial Growth and Strategy
2M ago
8K
BCRX
BioCryst raises FY25 net ORLADEYO revenue view to $590M-$600M
Premium
The Fly
BioCryst raises FY25 net ORLADEYO revenue view to $590M-$600M
2M ago
BCRX
BioCryst reports Q3 adjusted EPS 16c, consensus 8c
Premium
The Fly
BioCryst reports Q3 adjusted EPS 16c, consensus 8c
2M ago
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >